Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
325.62
-7.23 (-2.17%)
Feb 25, 2026, 12:21 PM EST - Market open
Alnylam Pharmaceuticals Analyst Ratings
Total Analysts
28
Consensus Rating
Strong Buy
Price Target
$472.78
Upside
+45.19%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $510 | Strong Buy | Reiterates | $510 | +56.62% | Feb 18, 2026 |
| Freedom Capital Markets | Freedom Capital Markets | Hold → Strong Buy Upgrades $470 → $410 | Hold → Strong Buy | Upgrades | $470 → $410 | +25.91% | Feb 17, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $415 → $429 | Strong Buy | Maintains | $415 → $429 | +31.75% | Feb 17, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $475 → $425 | Strong Buy | Maintains | $475 → $425 | +30.52% | Feb 13, 2026 |
| Needham | Needham | Strong Buy Maintains $529 → $510 | Strong Buy | Maintains | $529 → $510 | +56.62% | Feb 12, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $495 → $408 | Hold | Maintains | $495 → $408 | +25.30% | Jan 30, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $529 → $462 | Strong Buy | Maintains | $529 → $462 | +41.88% | Jan 30, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $570 → $510 | Strong Buy | Maintains | $570 → $510 | +56.62% | Jan 30, 2026 |
| Barclays | Barclays | Buy Initiates $527 | Buy | Initiates | $527 | +61.85% | Jan 28, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $500 → $465 | Buy | Maintains | $500 → $465 | +42.80% | Jan 20, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $479 → $376 | Hold | Maintains | $479 → $376 | +15.47% | Jan 20, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $530 → $529 | Strong Buy | Maintains | $530 → $529 | +62.46% | Jan 12, 2026 |
| Needham | Needham | Strong Buy Maintains $520 → $529 | Strong Buy | Maintains | $520 → $529 | +62.46% | Jan 12, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $535 → $530 | Strong Buy | Maintains | $535 → $530 | +62.77% | Jan 8, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $370 → $351 | Hold | Maintains | $370 → $351 | +7.79% | Dec 15, 2025 |
| Stifel | Stifel | Strong Buy Maintains $495 → $508 | Strong Buy | Maintains | $495 → $508 | +56.01% | Dec 11, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.